Introduction {#Sec1}
============

The presence of coronary artery calcium (CAC) is a marker of vascular injury and related to the extent of coronary atherosclerotic burden.[@CR1]-[@CR3] Computed tomography (CT) is a routinely used and a well-validated non-invasive imaging modality for the assessment and quantification of coronary atherosclerosis as represented by CAC.[@CR3] Previous studies have shown a positive relation between CAC and the anatomic severity of coronary artery disease (CAD),[@CR2],[@CR4],[@CR5] even after correction for traditional risk factors.[@CR6]-[@CR8] These risk factors in turn are known to affect myocardial perfusion, even in the absence of CAD.[@CR9] The incremental value of CAC over traditional risk factors to predict coronary vasodilator dysfunction and inherent myocardial blood flow (MBF) impairment is only scarcely documented.[@CR10]-[@CR14] Moreover, the results from these studies are conflicting and hampered by small sample size, varying patients populations, and the use of suboptimal imaging techniques to quantify MBF.

This study aimed to determine the relationship between CAC score and MBF in a large clinical cohort of symptomatic subjects suspected of and with risk factors for CAD undergoing hybrid ^15^O-water PET/CT imaging, in whom obstructive CAD was excluded by means of invasive (ICA) or CT-based coronary angiography (CTCA). In addition, the additive impact of CAC score on MBF over gender, age, and conventional CAD risk factors was explored.

Methods {#Sec2}
=======

Patient Population {#Sec3}
------------------

Data were obtained from a cohort of 249 patients being clinically evaluated for CAD and therefore referred for CTCA, CAC-scoring, and PET MBF measurements on a hybrid PET/CT scanner (Gemini TF 64, Philips Healthcare, Best, The Netherlands). Patients were referred because of stable (atypical) angina or an elevated risk for CAD (presence of two or more risk factors) in the absence of symptoms. Hypertension was defined as a blood pressure ≥140/90 mm Hg or the use of anti-hypertensive medication. Hypercholesterolemia was defined as total cholesterol level ≥5 mmol/L or treatment with cholesterol lowering medication. Patients were classified as having diabetes if they were receiving treatment with oral hypoglycemic drugs or insulin. A positive family history of CAD was defined by the presence of CAD in first-degree relatives younger than 55 years in men or 65 years in women. Obstructive CAD was considered to have been ruled out when either one of the following criteria had been met: (1) absence of a luminal stenosis of more than 50% at ICA (N.B. Referral for ICA was left to the discretion of the treating physician); (2) when ICA was not available, a CTCA of sufficient quality enabling adequate grading of all major coronary segments which did not display a stenosis of more than 50%. Exclusion criteria were atrial fibrillation, second- or third-degree atrioventricular block, symptomatic asthma, pregnancy, or a documented history of CAD. A history of CAD was defined as a prior percutaneous coronary intervention, coronary artery bypass graft surgery, or a previous myocardial infarction. A total of 173 out of the 249 evaluated patients met these criteria and are described in the current study (78 men: mean age 55, range 33-79 years; and 95 women: mean age 57, range 31-84 years). Electrocardiography did not show signs of a previous myocardial infarction, and echocardiography showed a normal left ventricular function without wall motion abnormalities in all patients. CAD pre-test likelihood was determined according to the Diamond and Forrester criteria,[@CR15] using percent cutoffs of \<13.4%, \>87.2%, and in between for low, high, and intermediate pre-test likelihood, respectively.

PET Imaging {#Sec4}
-----------

Patients were instructed to refrain from intake of products containing caffeine or xanthine 24 hours prior to the scan. After a scout CT for patient positioning and 2 minutes after the start of intravenous adenosine infusion 140 μg · kg^−1^ · min^−1^, 370 MBq of ^15^O-water was injected as a 5 mL (0.8 mL · s^−1^) bolus, followed immediately by a 35-mL saline flush (2 mL · s^−1^). A 6-minute emission scan was started simultaneously with the administration of ^15^O-water. This dynamic scan sequence was followed immediately by a respiration-averaged low dose CT scan (LD-CT) to correct for attenuation (55 mAs; rotation time, 1.5 s; pitch, 0.825; collimation, 16 × 0.625; acquiring 20 cm in 37 s) during normal breathing.[@CR16] Adenosine infusion was terminated after the LD-CT. After an interval of 10 minutes to allow for decay of radioactivity and washout of adenosine, an identical PET sequence was performed during resting conditions. Images were reconstructed using the 3D row action maximum likelihood algorithm into 22 frames (1 × 10, 8 × 5, 4 × 10, 2 × 15, 3 × 20, 2 × 30, and 2 × 60 seconds), applying all appropriate corrections. Parametric MBF images were generated and quantitative analysis was performed using in-house developed software, Cardiac VUer.[@CR17],[@CR18] MBF was expressed in mL · min^−1^ · g^−1^ of perfusable tissue and analyzed according to the 17-segment model of the American Heart Association.[@CR19] In addition to calculating the MBF for the left ventricle as a whole, MBF was calculated for each of three vascular territories (LAD, left anterior descending; LCx, left circumflex; and RCA, right coronary artery).

CT Imaging {#Sec5}
----------

Patients with a stable heart rate below 65 bpm (either spontaneous or after administration of oral and/or intravenous metoprolol) underwent a CT scan for calcium scoring and/or CTCA. A standard scanning protocol was applied, with 64 × 0.625-mm section collimation, 420-ms gantry rotation time, 120-kV tube voltage, and a tube current of 800 to 1000 mA (for CTCA), and 100 to 120 mA (for calcium scoring) depending on patients body size. All scans were performed with electrocardiogram-gated dose modulation to decrease the radiation dose. Calcium scoring was obtained during a single breath hold and coronary calcification was defined as a plaque with an area of 1.03 mm^2^ and a density ≥130 HU. The CAC score was calculated according to the method described by Agatston.[@CR20] After calcium scoring a CTCA was performed, whereby a bolus of 100-mL iodinated contrast agent was injected intravenously (5 mL · s^−1^) followed by a 50 mL NaCl 0.9% flush. All CT-scans were analyzed with a 3-dimensional workstation (Brilliance, Philips Medical Systems, Best, The Netherlands) by an experienced radiologist and cardiologist who were blinded to the PET-results. The coronary tree was evaluated according to a 16-segment coronary artery model modified from the American Heart Association.[@CR21]

Invasive Coronary Angiography {#Sec6}
-----------------------------

ICA was performed according to standard clinical protocols. The coronary tree was divided to a 16-segment coronary artery model modified from the American Heart Association.[@CR21] Significant CAD was ruled out when no stenosis was present or the diameter stenosis was visually scored ≤50%. All images were interpreted by at least two experienced interventional cardiologists.

Data Interpretation {#Sec7}
-------------------

CAC scores were calculated separately for the LAD (including the left main coronary artery), LCX artery, and RCA and then summed to provide a total CAC score. Coronary flow reserve (CFR) was defined as the ratio between hyperemic and baseline MBF. Coronary vascular resistance (mm Hg · mL · min^−1^ · g^−1^) during hyperemia was calculated by dividing mean arterial pressure (MAP) by hyperemic MBF.[@CR22] Furthermore, to study heterogeneity in MBF, the coefficient of variation (COV) was calculated on a per patient basis as the ratio of the standard deviation of the 17 myocardial segments and mean hyperemic MBF for that patient. Finally, to explore a potential perfusion decline along the course of the coronary artery from proximal to distal segments, the longitudinal perfusion gradient was calculated according to the method previously described by Hernandez-Pampaloni et al[@CR23] and initially proposed by Gould et al.[@CR24]

Statistical Analysis {#Sec8}
--------------------

Continuous variables are presented as mean values ± SD, whereas categorical variables are expressed as actual numbers. For most analyses, we categorized CAC into 4 groups (0, 0.01-99.9, 100-399.9, and ≥400) to accommodate the fact that 52 % of the studied subjects had a CAC score of 0. The ln (CAC score + 1) transformation better normalized CAC distribution. Continuous variables between males and females were compared using the paired or unpaired two-sided Student's *t* test, as appropriate. Comparison of differences in perfusion parameters across increasing levels of CAC score were performed using one-way analysis of variance (ANOVA) with Bonferroni's correction for multiple pair-wise comparisons for localizing the source of the difference. Evaluation of relationships between variables was performed using Spearman's rank correlation analysis. Univariable linear regression analyses were performed to examine the relationship between cardiac risk factors, age, gender, ln(CAC + 1) score and change in hyperemic MBF and CFR. In addition, predictors associated with hyperemic MBF and CFR, based on evidence from the literature,[@CR9] were included simultaneously in a multiple linear regression model using backward elimination. A *P* value ≤.05 (two-sided) was considered statistically significant. All statistical analysis was performed using SPSS software package (SPSS 15.0, Chicago, IL).

Results {#Sec9}
=======

Significant CAD was considered to be ruled out by ICA (44) and CTCA (129) in all patients (n = 173). Patient characteristics are shown in Table [1](#Tab1){ref-type="table"}. The 173 subjects included had a global baseline MBF of 1.05 ± 0.34 mL · min^−1^ · g^−1^. During adenosine-induced hyperemia, MBF increased significantly to 3.40 ± 1.19 mL · min^−1^ · g^−1^ (*P* \< .001). Coronary flow reserve (CFR) averaged 3.45 ± 1.32. The median CAC score in this cohort of symptomatic patients was 0 (interquartile range 0-31). Ninety-one of hundred and seventy-three patients (52%) had a CAC score of zero. Of those with CAC, the CAC score was 0.1-99.9, 100-399.9, and ≥ or =400 in 31%, 12%, and 5% of patients, respectively.Table 1Patient characteristics (n = 173)CharacteristicsN (%) or mean ± SDAge (years)56 ± 10Male gender78 (45%)BMI (kg · m^−2^)27 ± 4Diabetes36 (21%)Hypertension75 (43%)Hypercholesterolemia53 (31%)Smoking history69 (40%)Family history84 (49%)Reason for referral Typical angina pectoris36 (21%) Atypical angina pectoris59 (34%) Non-anginal chest pain57 (33%) High risk, no chest discomfort21 (12%)Pre-test likelihood of CAD0.37 ± 0.30*CAD*, Coronary artery disease; *BMI*, body mass index.

Hemodynamics {#Sec10}
------------

Table [2](#Tab2){ref-type="table"} summarizes the hemodynamic characteristics. During adenosine-induced hyperemia, heart rate, systolic blood pressure, and rate-pressure product increased significantly compared to baseline, whereas no significant changes occurred in diastolic blood pressure.Table 2Systemic hemodynamics at baseline and hyperemiaParameterMean value ± SDHeart rate (bpm) Baseline62 ± 10 Hyperemia81 ± 13\*Systolic blood pressure (mm Hg) Baseline113 ± 19 Hyperemia115 ± 19\*Diastolic blood pressure (mm Hg) Baseline60 ± 9 Hyperemia60 ± 9Mean arterial pressure (mm Hg) Baseline78 ± 11 Hyperemia78 ± 12Rate-pressure product Baseline7064 ± 2019 Hyperemia9445 ± 2407\**Bpm*, Beats per minute.\* *P* \< .05 vs baseline.

Per Patient Analysis {#Sec11}
--------------------

Stratification of patients into four groups based on their CAC scores (0, 0.01-99.9, 100-399.9, and ≥400) resulted in a comparable global baseline MBF among the four CAC groups, whereas hyperemic MBF (3.70, 3.30, 2.68, and 2.53 mL · min^−1^ · g^−1^) and CFR (3.70, 3.32, 2.94, and 2.93) gradually decreased with increasing CAC levels (Figure [1](#Fig1){ref-type="fig"}A, B). The COV, as a marker of heterogeneity in MBF, was comparable across all CAC score groups during both resting (*P* = .27) and stress conditions (*P* = .78) (Figure [2](#Fig2){ref-type="fig"}A). Furthermore, comparison of hyperemic MBF in the base-to-apex direction demonstrated no longitudinal perfusion gradient with increasing CAC scores (*P* = .67, Figure [2](#Fig2){ref-type="fig"}B). Minimal coronary vascular resistance (CVR) displayed a significant stepwise increase (*P* \< .001) with increasing total CAC score (Figure [3](#Fig3){ref-type="fig"}A). Spearman's rank correlations of baseline MBF, hyperemic MBF, CFR, minimal CVR, and COV of hyperemic MBF with ln (CAC + 1) score were −0.08 (*P* = .27), −0.32 (*P*\< .001), −0.21 (*P* \< .01), 0.33 (*P* \< .001), and −0.05 (*P* = .54), respectively.Figure 1Per-patient (**A**, **B**) and per-vessel analysis (**C**, **D**). Relationships between coronary artery calcium (CAC) and **A**, **C** myocardial blood flow (MBF), and **B**, **D** coronary flow reserve (CFR)Figure 2Relationships between coronary artery calcium (CAC) and **A** coefficient of variation (COV), and **B** longitudinal perfusion gradient (mid-ventricular to apical regions)Figure 3Per-patient analysis (**A**) and per-vessel analysis (**B**). Relationships between coronary artery calcium (CAC) and hyperemic coronary vascular resistance (CVR)

Per Vessel Analysis {#Sec12}
-------------------

In 173 patients, a total of 519 vascular territories were analyzed. The correlation between per-vessel ln (CAC + 1), hyperemic MBF (*r* = −0.31, *P* \< .001), CFR (*r* = −0.22, *P* \< .001), and minimal CVR (*r* = 0.33, *P* \< .001) was modest but statistically significant. Furthermore, when grouped according to per-vessel CAC score, baseline MBF was comparable across increasing levels of CAC score (*P* = .18). In addition, mean hyperemic MBF (3.62, 2.97, 2.66, and 2.35 mL · min^−1^ · g^−1^), CFR (3.65, 3.09, 3.15, and 2.36) progressively declined across increasing CAC levels (*P* \< .001) (Figure [1](#Fig1){ref-type="fig"}C, D). Minimal CVR showed a stepwise increase across increasing per-vessel CAC levels (24, 30, 30, and 34 mm Hg · mL · min^−1^ · g^−1^, respectively, *P* \< .001) (Figure [3](#Fig3){ref-type="fig"}B). In addition, hyperemic MBF and CFR decreased with increasing number of coronary vessels containing atherosclerosis (Figure [4](#Fig4){ref-type="fig"}).Figure 4Relationship between number of vessels containing CAC and myocardial blood flow (MBF) (**A**), and **B** coronary flow reserve

Predictors of Hyperemic MBF and CFR {#Sec13}
-----------------------------------

Univariable regression analyses demonstrated that age (*P* \< .01), male gender (*P* \< .001), BMI (*P* \< .01), diabetes (*P* = .04), hypercholesterolemia (*P* = .04), and ln(CAC + 1) score (*P* \< .001) displayed an inverse relationship with hyperemic MBF. Furthermore, multivariable linear regression analyses were performed with predictors which were selected based on evidence from the literature on their association with an impaired hyperemic MBF or CFR.[@CR9] When these predictors, including ln(CAC + 1) score, were put simultaneously into a multivariable regression model only age, male gender, BMI, and hypercholesterolemia were identified to have an independently negative impact on hyperemic MBF (Table [3](#Tab3){ref-type="table"}a). In addition, univariable and multivariable regression analyses were performed to identify predictors of CFR. Univariable analyses showed that age (*P* \< .01), BMI (*P* = .03), diabetes (*P* \< .01), hypertension (*P* = .04), and total ln(CAC + 1) (*P* \< .01) were associated with a negative impact on CFR. Multivariable regression analyses demonstrated that only age and diabetes were independently correlated with a diminished CFR (Table [3](#Tab3){ref-type="table"}b).Table 3Backward multiple linear regression analysis with hyperemic MBF (a) and CFR (b) as the dependent variablesIndependent variableβ*P* value(a) Age−0.03\<.001 Male gender−1.07\<.001 BMI−0.07\<.001 Hypercholesterolemia−0.36.04(b) Age−0.03\<.01 Diabetes mellitus type II−0.51.04After forcing age, gender, BMI, diabetes type II, hypertension, smoking history, hypercholesterolemia, family history and ln(CAC + 1) into the model. Only variables that had a *P* ≤ 0.05 were considered in the final model. *MBF*, Myocardial blood flow; *CFR*, coronary flow reserve; *BMI*, body mass index.

Discussion {#Sec14}
==========

The current study was conducted to explore the quantitative relationship between CAC and coronary vasodilator response in patients who were being evaluated for CAD by hybrid ^15^O-water PET/CT. In symptomatic patients with multiple risk factors and non-obstructive CAD, CAC score does not add incremental information over age, gender, and traditional risk factors to predict impairment of hyperemic MBF and CFR. Of interest, CAC was also not related to hyperemic perfusion heterogeneity or the longitudinal perfusion gradient from base to apex.

In line with the majority of previous studies, resting MBF was not related to the extent of coronary calcification.[@CR10]-[@CR13] This observation is not surprising as resting MBF is modulated in response to myocardial metabolic demand and remains preserved till the point of a subtotal coronary stenosis.[@CR25],[@CR26] Schindler et al,[@CR14] however, have documented an inverse relation between CAC and resting MBF in a cohort of diabetic patients. These results may be explained by alterations in the hormonal milieu and insulin levels which are known to affect resting MBF in the more advanced stages or diabetes with coronary injury.[@CR27]

The negative correlation between the extent of coronary calcium and hyperemic MBF and flow reserve is in concordance with prior studies in asymptomatic controls, patients suspected of CAD, and diabetics.[@CR10],[@CR11],[@CR28] Only studies including small number of patients or employing qualitative flow measurements instead of absolute quantitative MBF measurements have not been able to reproduce the relation between vasodilator function and CAC.[@CR12],[@CR13] Multivariate analysis revealed that only age, male gender, BMI, and hypercholesterolemia were associated with reduced stress perfusion. Of interest, CAC score was not an independent predictor of a diminished hyperemic MBF. This is consistent with previous work showing that CAC score has little incremental value in predicting a diminished vasodilator response.[@CR10],[@CR11] In contrast to the current data, in these previous studies significant CAD was not excluded and could therefore have contributed to the observed independent (weak) relationship between CAC and impaired MBF. Thus, although CAC is a strong predictor for future cardiovascular events and reflects total coronary atherosclerotic burden, the current results implicate that CAC score in symptomatic patients with multiple risk factors and no obstructive epicardial CAD, does not add incremental information regarding MBF over age, gender, BMI, and established coronary risk factors.

Another aspect of this study was to investigate the relation between heterogeneity of hyperemic MBF and CAC as some of the aforementioned studies have indicated such an relation.[@CR12],[@CR14] It was therefore hypothesized that increased levels of calcium may induce heterogeneity between coronary perfusion territories, on the one hand, and a longitudinal perfusion gradient from base to apex, on the other hand. Gould et al[@CR24] initially introduced the latter concept, where patients with non-significant CAD displayed a gradual longitudinal decline in hyperemic MBF from base to apex as measured with ^13^N-ammonia PET. These results were later confirmed by Hernandez-Pampaloni et al[@CR23] in asymptomatic patients with an increased risk profile for CAD. Invasive measurements have indeed demonstrated that a gradual hyperemic perfusion pressure gradient exists along the course of mild atherosclerotic coronary arteries.[@CR29] In the current study, however, there was no relationship between heterogeneity of hyperemic MBF and CAC. Moreover, no perfusion gradient was detected between the mid and the apical sections of the left ventricle with increasing CAC scores during adenosine-induced hyperemia. Several factors may have contributed to these observations. First, there might be differences between study populations. In the current study, 52% of patients displayed no coronary calcium and the lack of longitudinal perfusion gradient may well be explained by the lack of coronary artery disease in these patients in contrast to the cohort of patients described by Gould et al.[@CR24] Second, there are some methodological differences between studies. Previously documented base to apex gradients have been investigated using ^13^N-ammonia PET almost a decade ago. The scanner used in the current study, however, is characterized by a higher spatial resolution and hence less affected by partial volume effects. Moreover, the modeling procedure of ^15^O-water incorporates an intrinsic correction for partial volume effects. As wall thickness progressive declines from base to apex, part of the observed longitudinal perfusion gradient may be caused by partial volume effects. Third, the perfusion gradient was measured over only a relatively short longitudinal distance of the left ventricle, i.e., from the mid-ventricular to the apical portion in concordance with Hernandez-Pampaloni et al.[@CR23] This approach was chosen to avoid potential inclusion of the outflow tract of the left ventricle in the perfusion estimates. Nevertheless, when the longitudinal gradient was measured from the basal to the apical portion, no myocardial perfusion gradient was demonstrated in the current population (data not shown). In addition, the limited number of patients in the group having a CAC score ≥ 400 could have introduced bias. Further studies in larger populations are warranted to assess the effect of CAC on MBF heterogeneity.

Study Limitations {#Sec15}
-----------------

Some limitations of our study that may affect the current findings must be acknowledged. Significant CAD was presumed to have been excluded by invasive or CT-based coronary angiography. The number of routinely performed invasive coronary angiographies in the current population was limited. Although CTCA is an excellent tool for ruling out significant CAD with a negative predictive value of 97% to 99%,[@CR30],[@CR31] some patients with hemodynamic significant CAD may have been included. Furthermore, the current data were obtained in predominantly symptomatic patients and therefore the results may not be extrapolated to, for example, asymptomatic subjects. Studies in asymptomatic subjects have displayed conflicting results and therefore larger studies are warranted to further investigate the relationship between CAC score and coronary vasodilator function in specific subpopulations. Finally, it must be emphasized that for subgroup analyses the studied patient population was too small to draw definite conclusions.

Conclusions {#Sec16}
===========

In patients with an intermediate pre-test likelihood of CAD and with multiple CAD risk factors there was a statistically significant inverse correlation between hyperemic MBF, CFR, and the extent of CAC. However, this association disappeared after adjusting for age, gender, BMI, and conventional risk factors. These results suggest that CAC score does not add incremental value regarding hyperemic MBF and CFR over established CAD risk factors in patients with an intermediate pre-test likelihood of CAD and no obstructive epicardial CAD. Therefore, coronary artery calcifications and vasodilator reactivity reflect different aspects of coronary atherosclerosis.
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